Live Breaking News & Updates on Morphosys Company Profile

Stay updated with breaking news from Morphosys company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MorphoSys (MOR) to Release Quarterly Earnings on Monday

MorphoSys (NASDAQ:MOR – Get Free Report) will release its earnings data before the market opens on Monday, May 27th. Analysts expect MorphoSys to post earnings of ($1.30) per share for the quarter. MorphoSys (NASDAQ:MOR – Get Free Report) last posted its quarterly earnings data on Monday, April 29th. The company reported ($2.24) EPS for the […] ....

United States , Morphosys Company Profile , Wells Fargo Company , Get Free Report , Wells Fargo , Morphosys Daily ,

MorphoSys (MOR) Set to Announce Quarterly Earnings on Monday

MorphoSys (NASDAQ:MOR – Get Free Report) will be issuing its quarterly earnings data before the market opens on Monday, May 27th. Analysts expect the company to announce earnings of ($1.30) per share for the quarter. MorphoSys (NASDAQ:MOR – Get Free Report) last posted its earnings results on Monday, April 29th. The company reported ($2.24) earnings […] ....

United States , Wells Fargo Company , Morphosys Company Profile , Get Free Report , Wells Fargo , Morphosys Daily ,

MorphoSys (NASDAQ:MOR) Sets New 1-Year High at $18.38

MorphoSys (NASDAQ:MOR) Sets New 1-Year High at $18.38
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United States , Morphosys Company Profile , Morgan Stanley , Quadrant Capital Group , Wells Fargo Company , Exchange Traded Concepts , Virtu Financial , Get Free Report , Capital Group , Traded Concepts , Financial Markets , Morphosys Daily ,

MorphoSys AG (NASDAQ:MOR) Receives $11.78 Consensus Target Price from Brokerages

MorphoSys AG (NASDAQ:MOR) Receives $11.78 Consensus Target Price from Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Leerink Partnrs , Virtu Financial , Cubist Systematic Strategies , Jpmorgan Chase Co , Wells Fargo Company , Pricet Rowe Associates Inc , Morgan Stanley , Goldman Sachs Group Inc , Morphosys Company Profile , Get Free Report , Sachs Group , Systematic Strategies , Sys Stock Down , Get Free , Morphosys Daily ,

Wells Fargo & Company Reaffirms Overweight Rating for MorphoSys (NASDAQ:MOR)

Wells Fargo & Company reaffirmed their overweight rating on shares of MorphoSys (NASDAQ:MOR – Free Report) in a report issued on Monday, Benzinga reports. They currently have a $17.00 price objective on the stock. Several other analysts also recently commented on MOR. Leerink Partnrs restated a market perform rating on shares of MorphoSys in a […] ....

United States , Leerink Partnrs , Wells Fargo Company , Sigma Securities , Qube Research Technologies Ltd , Jpmorgan Chase Co , Morphosys Company Profile , Virtu Financial , Morgan Stanley , Goldman Sachs Group , Wells Fargo , Free Report , Moderate Buy , Get Free Report , Technologies Ltd , Two Sigma Securities , Morphosys Daily , Nasdaq Mor , Reiterated Rating ,